Transition of patients with mucopolysaccharidosis from paediatric to adult care

Publication date: December 2019Source: Molecular Genetics and Metabolism Reports, Volume 21Author(s): C. Lampe, B. McNelly, A.K. Gevorkian, C.J. Hendriksz, T.V. Lobzhanidze, J. Pérez-López, K.M. Stepien, N.D. Vashakmadze, M. Del ToroAbstractMucopolysaccharidoses (MPS) are rare disorders associated with enzyme deficiencies, resulting in glycosaminoglycan (GAG) accumulation in multiple organ systems. As patients increasingly survive to adulthood, the need for a smooth transition into adult care is essential. Using case studies, we outline strategies and highlight the challenges of transition, illustrating practical solutions that may be used to optimise the transition process for patients with MPS disorders.Seven MPS case studies were provided by four European inherited metabolic disease centres; six of these patients transferred to an adult care setting and the final patient remained under paediatric care. Of the patients who transferred, age at the start of transition ranged between 14 and 18 years (age at transfer ranged from 16 to 19 years).While there were some shared features of transition strategies, they varied in duration, the healthcare professionals involved and the management of adult patients with MPS. Challenges included complex symptoms, patients' unwillingness to attend appointments with unfamiliar team members and attachment to paediatricians. Challenges were resolved by starting transition at an early age, educating patients and families, and providing r...
Source: Molecular Genetics and Metabolism Reports - Category: Genetics & Stem Cells Source Type: research